Explanation

Controlled substance prescribing via telehealth is governed by a complex and evolving framework of DEA, federal, and state regulations. Following the COVID-19 public health emergency, significant changes were made to telehealth prescribing rules, and these regulations continue to evolve. PMHNPs must stay current with the applicable requirements in their practicing jurisdictions, including whether an initial in-person evaluation is required before telehealth prescribing of controlled substances, patient identity verification procedures, PDMP checking requirements, state-specific limitations, and any special DEA registration requirements. The regulatory landscape is dynamic, making it essential for PMHNPs to regularly verify current requirements.

Key Takeaway

Controlled substance prescribing via telehealth is governed by overlapping DEA, federal, and state regulations that have evolved significantly.